Studies also suggested that activation of c-KIT enhances the expression of VEGF that can be suppressed by imatinib, an inhibitor of c-KIT in gastrointestinal stromal tumor cells, which thereby has an impact on tumor angiogenesis [159, 160]. Here, VEGFA is linked to neoplasm.